机译:Bevacizumab诱导的高血压的遗传标记
Vesalius Research Center VIB Campus Gasthuisberg Herestraat 49 Box 912 3000 Leuven Belgium;
Vesalius Research Center VIB Campus Gasthuisberg Herestraat 49 Box 912 3000 Leuven Belgium;
F. Hoffmann-La Roche Basel Switzerland;
Mount Vernon Cancer Centre Northwood United Kingdom;
Department of Medicine Princess Margaret Hospital Toronto ON Canada;
Institut Gustave Roussy Villejuif France;
Digestive Oncology University Hospitals Leuven Leuven Belgium;
Acclarogen Ltd St John's Innovation Centre Cambridge United Kingdom;
Vesalius Research Center VIB Campus Gasthuisberg Herestraat 49 Box 912 3000 Leuven Belgium;
Genentech Inc South San Francisco CA United States;
F. Hoffmann-La Roche Basel Switzerland;
F. Hoffmann-La Roche Basel Switzerland;
Anti-angiogenesis; Bevacizumab; Hypertension; Predictive biomarker; Single nucleotide polymorphism;
机译:贝伐单抗诱发的高血压的遗传标记
机译:贝伐单抗诱发的高血压是用贝伐单抗治疗的复发性胶质母细胞瘤患者预后改善的指标
机译:Bevacizumab诱导的高血压遗传易感性
机译:高血压和2型糖尿病女性血管风险增加的标志
机译:贝伐单抗诱发的高血压的遗传预测因子。
机译:遗传变异预测贝伐单抗在ECOG-5103和ECOG-2100中引起高血压
机译:贝伐单抗诱发的高血压的遗传标记